Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes

Brett Grover1, Donna Buckley, Arthur R Buckley

  • 1College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH 45267-0004, USA.

Insights

Experimental diabetes impairs organic cation transport in rats by reducing key transporter proteins. Insulin treatment reversed these deficits, suggesting potential therapeutic targets for diabetic kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Diabetology

Background:

  • Organic cation transport is crucial for kidney function.
  • A functional deficit in organic cation transport has been observed in diabetic rats.
  • The underlying mechanism for this deficit remains unclear.

Purpose of the Study:

  • To investigate the hypothesis that experimental diabetes decreases the expression of organic cation transporters at the basolateral membrane.
  • To elucidate the molecular mechanisms behind impaired organic cation transport in diabetes.

Main Methods:

  • Streptozotocin-induced diabetic rat model with varying durations.
  • Kinetic analysis of tetraethylammonium accumulation in proximal tubular cells.
  • Northern and immunoblot analysis for organic cation transporter (OCT) expression (rOCT1, rOCT2).
  • Insulin treatment as an intervention.

Main Results:

  • Diabetic rats showed significantly lower Vmax for tetraethylammonium accumulation, indicating reduced transporter function.
  • Protein expression of rOCT1 and rOCT2 decreased with diabetes duration (up to 50% and 70%, respectively).
  • roct2 mRNA levels decreased by 50%, while roct1 mRNA remained unchanged; insulin prevented these reductions.

Conclusions:

  • Experimental diabetes reduces the expression of organic cation transporters rOCT1 and rOCT2.
  • Diabetes affects roct2 expression transcriptionally and/or translationally, but rOCT1 deficits may stem from posttranscriptional alterations.
  • Insulin therapy can restore normal transporter levels, highlighting its potential in managing diabetic nephropathy.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...